Global Zebrafish as a Model Organism Market Growth (Status and Outlook) 2022-2028
Request Sample
Pre-order Enquiry
Request Customization
Check Discounts
The global market for Zebrafish as a Model Organism is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Zebrafish as a Model Organism market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Zebrafish as a Model Organism market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Zebrafish as a Model Organism market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Zebrafish as a Model Organism market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Zebrafish as a Model Organism players cover Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide and Pentagrit, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Zebrafish as a Model Organism market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Zebrafish as a Model Organism market, with both quantitative and qualitative data, to help readers understand how the Zebrafish as a Model Organism market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Zebrafish as a Model Organism market and forecasts the market size by Type (Toxicity Testing Services, Transgenesis and Gene Editing Services and Disease Models), by Application (Pharmaceutical, Biotechnology, Chemical and Cosmetics), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Toxicity Testing Services
Transgenesis and Gene Editing Services
Disease Models
Others
Segmentation by application
Pharmaceutical
Biotechnology
Chemical
Cosmetics
Water Quality Monitoring
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Shanghai Model Organisms Center, Inc.
ZeClinics
InVivo Biosystems
Biobide
Pentagrit
Evotec
Aurigene Pharmaceutical Services
Ikan Biotech
Bioreperia
Hangzhou Hunter Biotechnology Co., Ltd.
YSY BIOTECH
Eze-Rinka
INVENesis
FEIFAN TEST
Charles River Laboratories
Chapter Introduction
Chapter 1: Scope of Zebrafish as a Model Organism, Research Methodology, etc.
Chapter 2: Executive Summary, global Zebrafish as a Model Organism market size and CAGR, Zebrafish as a Model Organism market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Zebrafish as a Model Organism revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Zebrafish as a Model Organism revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Zebrafish as a Model Organism market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, Ikan Biotech and Bioreperia, etc.
Chapter 14: Research Findings and Conclusion
The APAC Zebrafish as a Model Organism market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Zebrafish as a Model Organism market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Zebrafish as a Model Organism market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Zebrafish as a Model Organism market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Zebrafish as a Model Organism players cover Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide and Pentagrit, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Zebrafish as a Model Organism market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Zebrafish as a Model Organism market, with both quantitative and qualitative data, to help readers understand how the Zebrafish as a Model Organism market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Zebrafish as a Model Organism market and forecasts the market size by Type (Toxicity Testing Services, Transgenesis and Gene Editing Services and Disease Models), by Application (Pharmaceutical, Biotechnology, Chemical and Cosmetics), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Toxicity Testing Services
Transgenesis and Gene Editing Services
Disease Models
Others
Segmentation by application
Pharmaceutical
Biotechnology
Chemical
Cosmetics
Water Quality Monitoring
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Shanghai Model Organisms Center, Inc.
ZeClinics
InVivo Biosystems
Biobide
Pentagrit
Evotec
Aurigene Pharmaceutical Services
Ikan Biotech
Bioreperia
Hangzhou Hunter Biotechnology Co., Ltd.
YSY BIOTECH
Eze-Rinka
INVENesis
FEIFAN TEST
Charles River Laboratories
Chapter Introduction
Chapter 1: Scope of Zebrafish as a Model Organism, Research Methodology, etc.
Chapter 2: Executive Summary, global Zebrafish as a Model Organism market size and CAGR, Zebrafish as a Model Organism market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Zebrafish as a Model Organism revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Zebrafish as a Model Organism revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Zebrafish as a Model Organism market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, Ikan Biotech and Bioreperia, etc.
Chapter 14: Research Findings and Conclusion
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
LPI-21738333
16-Sep-2022
113
16-Sep-2022
113
License
